期刊文献+

2型糖尿病患者N末端前体B型尿钠肽水平变化及其影响因素分析

The changes and influence factors analysis of the NT-pro BNP levels in type 2 diabetes mellitus patients
原文传递
导出
摘要 目的 探讨2型糖尿病(T2DM)老年患者N末端前体B型尿钠肽(NT-pro BNP)的变化及其影响因素,为T2DM老年患者心血管疾病的预防提供可参考依据。方法 选取2013年2月至2015年2月开滦总医院收治的T2DM老年患者150例为研究对象,依据是否患有高血压病及大量蛋白尿分为观察1组(单纯糖尿病)50例,观察2组(糖尿病合并高血压)75例,观察3组(糖尿病合并高血压及大量蛋白尿)25例;并选取同期健康查体人群50例为对照组。对各项实验室检测指标用SPSS 14.0软件进行χ2检验及方差分析,各因素相关性用Pearson相关性分析,NT-pro BNP水平的影响因素用多因素logistic回归分析。结果 观察2组和观察3组的血清NT-pro BNP水平[分别为(110.56±28.34)、(186.35±35.26)pg/L]明显高于对照组[(80.34±20.89)pg/L],差异均有统计学意义(P〈0.05);观察1组与对照组、观察2组和观察3组与观察1组之间的血清NT-pro BNP水平比较,差异均无统计学意义(P〉0.05)。Pearson相关性分析结果显示,年龄、糖尿病病程、高血压、收缩压(SBP)、大量蛋白尿、经皮冠状动脉介入治疗(PCI)史与NT-pro BNP水平呈正相关(r值分别为0.342、0.483、0.283、0.763、0.693和0.208,P〈0.05);多因素logistic回归分析结果示,年龄、SBP、大量蛋白尿是NT-pro BNP水平的独立影响因素(P〈0.05)。结论 T2DM合并高血压、大量蛋白尿老年患者的NT-pro BNP水平升高;应注意对高龄、高血压及大量蛋白尿T2DM患者心血管事件的预防。 Objective To investigate the changes and influence factors of the NT-proBNP levels in elderly patients with type 2 diabetes mellitus (T2DM) and to provide the basis for preventing cardiovascular diseases in elderly T2DM patients. Methods A total of 150 cases of elderly T2DM inpatients in Kailuan general hospital from February 2013 to February 2015 were selected as the subjects, the subjects were divided into group 1 (50 cases alone with T2DM), group 2 (75 T2DM cases with hypertension), group 3 (25 T2DM cases with hypertension and mass proteinuria), according to the hypertension and proteinuria; 50 healthy residents served as control group. SPSS 14.0 software was used to analyze the indexes of lab. examination with X2 test and ANOVA, the pearson correlation analysis was used to analyze the con'elation of various factors, the multivariable logistic regression analysis was utilized to analyze the influencing factors for NT-proBNP levels. Results The serum NT-proBNP levels (110.56±28.34 and 186.35±35.26 pg/L) of group 2 and 3 were significantly higher than that (80.34±20.89 pg/L) of the control group (P〈0.05); there were no significant differences of NT-proBNP levels between group 1 and control group, group 2 and group 3 or group 1 (P〉0.05 ). The pearson correlation analysis showed that the serum NT-proBNP levels were positively correlated with the age, duration of T2DM, hypertension, systolic blood pressure, mass proteinuria, and PCI (r values were 0.342, 0.483, 0.283, 0.763, 0.693 and 0.208, respectively; P〈O.05 ); the multivariable logistic regression analysis indicated that the age, SBP and massive proteinufia were the independent influence factors of the serum NT-proBNP levels (P〈0.05). Conclusion The serum NT-proBNP levels of the elderly T2DM patients with hypertension and massive proteinufia are the highest; the cardiovascular diseases in elderly T2DM patients with hypertension and massive proteinuria should be prevented.
出处 《中国慢性病预防与控制》 CAS 2016年第9期667-670,共4页 Chinese Journal of Prevention and Control of Chronic Diseases
基金 河北省卫生厅医学科学研究重点课题项目(20150841)
关键词 糖尿病 2型 高血压 蛋白尿 N末端前体B型钠尿肽 影响因素 Diabetes mellitus, type 2 Hypertension Proteinuria NT-proBNP Influencing factors
  • 相关文献

参考文献14

  • 1王德琴,周永华,丁宏胜,韩晓骏,严冲,苏如婷,杨小华,王姝琴,席巍.B型脑钠肽和可溶性血管细胞黏附分子1在2型糖尿病合并冠心病事件危险分层中的价值[J].中国糖尿病杂志,2014,22(9):778-780. 被引量:11
  • 2黄红宇,魏云玉,沈洪远.N末端脑利钠肽前体、脑利钠肽和醛固酮在2型糖尿病肾病中的临床意义[J].江苏医药,2013,39(8):953-954. 被引量:3
  • 30iflel S, Iqaasaolu S, Yldz G,et al. Association of left ventricular diastolic dysfunction with elevated NT-proBNP in type 2 diabetes mellitus patients with preserved ejection fraction: the supplemanta role of tissue doppler imaging parameters and NT-proBNP levels [ J ]. Diabetes Res Clin Pr, 2012,96(2):179-186.
  • 4俞红,金美娟,李进,王健,陈桂婷.2型糖尿病患者血脂异常对血浆脑钠肽的影响[J].中国糖尿病杂志,2011,19(5):358-360. 被引量:4
  • 5Hamano K, Abe M, Komi R, et al. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial is- chaemia in type 2 diabetes mellitus independent of mieroalbuminuria [J]. Diabetes Metab Res Rev, 2010,26(7):534-539.
  • 6yon Sehohen B J, Reinhard H, Hansen TW, et al. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomaftic patients with type 2 diabetes [ J ]. Cardiovasc Diabetol, 2015, 23( 14):59-62.
  • 7Meroufel DN, Ouhaibi-Djellouli H, Mediene-Benchekor S, et al. Examination of the brain natriuretic peptide rs198389 single- nucleotide polymorphism on type 2 diabetes mellitusand related phenotypes in an Algerian population[J]. Gene, 2015,28( 12): 1116- 1119.
  • 8Tanaka M, Sekioka R, Nishimura T, et al. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes inellitus: association with BNP and aldosterone levels[J]. Diabetes Res Clin Pract,2014,106(3):504-510.
  • 9Zannad F, Cannon CP, Cushman WC,et al. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double- blind trial [ J ]. Lancet, 2015, 35 ( 82 ):2067-2076.
  • 10Seki N, Matsumoto T, Fukazawa M,et al. Relationship between the brain natriuretic peptide (BNP) level and remission of diabetic nephropathy with microalbuminuria: a 3-year follow-up study [J]. Horm Metab Res,2015,47 ( 2 ): 138-144.

二级参考文献28

  • 1贾荣波,李建设,赵树芬,张晓燕.高敏C反应蛋白与2型糖尿病冠状动脉病变的相关性分析[J].现代诊断与治疗,2006,17(4):208-210. 被引量:12
  • 2韩红彦,万为国,王燕,杨琳.冠心病合并糖尿病患者C反应蛋白和尿酸变化及意义[J].疑难病杂志,2006,5(6):420-421. 被引量:7
  • 3Matsumura T,Kugiyama K,Sugiyama S,et al.Neutral endo-peptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cy-totoxity.J Clin Invest,1996,97:2192-2203.
  • 4Qi W,Mathisen P,Kjekshus J,et al.Natriuretic peptides in patients with aortic stenosis.Am Heart J,2001,142:725-732.
  • 5Thibault G,Lacasse A,Garcia R.Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP production in adipose tissue.Life Sci,1996,58:2345-2353.
  • 6De Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362:316-322.
  • 7Baughman KL.B-type natriuretic peptide-A window to the heart.N Engl J Med,2002,347:158-159.
  • 8Haug C,Metzele A,Kochs M,et al.Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end diastolic pressure.Clin Cardiol,1993,16:553-557.
  • 9Adlam D,Silcocks P,Sparrow N.Using BNP to develop a risk score for heart failure in primary care.Eur Heart J,2005,26:1086-1093.
  • 10Epshteyn V,Morrison K,Kazanegra R,et al.Utility of b-Type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes.Diabetes Care,2003,26:2081-2087.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部